CEACAM5 and colorectal carcinoma: Moreover, the NGS‐based methylation sequencing data indicated that the decrement in the methylated region in both 5‐Aza‐dC‐treated CRC cell lines occurred at −200 to −500 and −1000 to −1400 bp of the CEACAM5 promoter region (Figures S2 and S3).